Helix Management, Inc. is an investment advisory firm serving institutional investors and entrepreneurs. Helix advises investors on negotiated transactions, including direct investments in private and public life sciences companies and therapeutic product royalty and revenue streams. Helix has served as an advisor to institutional clients on proposed royalty-related transactions with an aggregate acquisition value in excess of $1 billion. Helix has advised fund of funds and family office investors on their healthcare alternative investment strategies, including investments in hedge funds and private equity funds. Helix counsels emerging management teams on operational growth strategies, including fundraising, investor relations, tax and due diligence.